1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
1.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Scope
1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016 & 2021 & 2027)
1.2.2 Serum Biomarkers
1.2.3 Cytokeratin-18 (CK 18) Marker
1.2.4 Inflammatory Markers
1.2.5 Others
1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts (2016-2027)
1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends (2016-2027)
2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Forecasts by Region
2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
2.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2016-2021)
2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
2.4.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
2.4.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
2.4.4 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
2.4.6 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Competition Landscape by Players
3.1 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Sales (2016-2021)
3.2 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Revenue (2016-2021)
3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
3.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Company (2016-2021)
3.5 Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Type
4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Type (2016-2021)
4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2016-2021)
4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2016-2021)
4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Type (2022-2027)
4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Type (2022-2027)
4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Type (2022-2027)
5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Application
5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Application (2016-2021)
5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2016-2021)
5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2016-2021)
5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Application (2022-2027)
5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Application (2022-2027)
5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Application (2022-2027)
6 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
6.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
6.1.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
6.1.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
6.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
6.2.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
6.2.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
6.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
6.3.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
6.3.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)
7 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
7.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
7.1.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
7.1.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
7.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
7.2.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
7.2.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
7.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
8.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
8.1.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
8.1.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
8.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
8.2.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
8.2.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
8.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
9.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
9.1.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
9.1.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
9.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
9.2.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
9.2.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
9.3 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
10.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
10.1.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
10.1.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
10.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
10.2.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
11.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
11.1.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
11.1.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
11.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
11.2.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
11.2.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
11.3 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
11.3.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
11.3.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Non-alcoholic Steatohepatitis (NASH) Biomarkers Business
12.1 Biopredictive
12.1.1 Biopredictive Corporation Information
12.1.2 Biopredictive Business Overview
12.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.1.5 Biopredictive Recent Development
12.2 Quest Diagnostics
12.2.1 Quest Diagnostics Corporation Information
12.2.2 Quest Diagnostics Business Overview
12.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.2.5 Quest Diagnostics Recent Development
12.3 Exalenz Bioscience
12.3.1 Exalenz Bioscience Corporation Information
12.3.2 Exalenz Bioscience Business Overview
12.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.3.5 Exalenz Bioscience Recent Development
12.4 GENFIT
12.4.1 GENFIT Corporation Information
12.4.2 GENFIT Business Overview
12.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.4.5 GENFIT Recent Development
12.5 Siemens Healthineers
12.5.1 Siemens Healthineers Corporation Information
12.5.2 Siemens Healthineers Business Overview
12.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.5.5 Siemens Healthineers Recent Development
12.6 ONE WAY LIVER
12.6.1 ONE WAY LIVER Corporation Information
12.6.2 ONE WAY LIVER Business Overview
12.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.6.5 ONE WAY LIVER Recent Development
12.7 Prometheus Laboratories
12.7.1 Prometheus Laboratories Corporation Information
12.7.2 Prometheus Laboratories Business Overview
12.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.7.5 Prometheus Laboratories Recent Development
12.8 Gilead Sciences
12.8.1 Gilead Sciences Corporation Information
12.8.2 Gilead Sciences Business Overview
12.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
12.8.5 Gilead Sciences Recent Development
13 Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Cost Analysis
13.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
13.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
14.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers
15 Market Dynamics
15.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
15.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Drivers
15.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
15.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Region (2016-2021)
Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Region (2016-2021)
Table 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share Forecast by Region (2022-2027)
Table 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Company (2016-2021)
Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Company (2016-2021)
Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites and Area Served
Table 19. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2016-2021)
Table 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Type (2016-2021)
Table 23. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2016-2021)
Table 25. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Type (2022-2027)
Table 26. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Type (2022-2027)
Table 28. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2022-2027)
Table 29. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2016-2021)
Table 30. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Application (2016-2021)
Table 31. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2016-2021)
Table 33. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2022-2027)
Table 34. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Application (2022-2027)
Table 35. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Application (2022-2027)
Table 37. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2022-2027)
Table 38. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 39. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 40. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 42. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 43. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 44. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 45. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 46. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 47. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 48. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 49. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 50. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 51. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 52. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 54. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 55. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 56. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 57. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 58. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 59. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 60. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 61. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 62. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 63. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 64. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 66. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 67. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 68. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 69. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 70. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 71. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 72. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 73. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 74. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 75. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 76. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 78. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 79. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 80. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 81. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 82. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 83. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 84. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 85. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 98. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
Table 99. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
Table 100. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
Table 102. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
Table 103. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 104. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
Table 105. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
Table 106. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
Table 107. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 108. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
Table 109. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
Table 110. Biopredictive Corporation Information
Table 111. Biopredictive Description and Business Overview
Table 112. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 114. Biopredictive Recent Development
Table 115. Quest Diagnostics Corporation Information
Table 116. Quest Diagnostics Description and Business Overview
Table 117. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 119. Quest Diagnostics Recent Development
Table 120. Exalenz Bioscience Corporation Information
Table 121. Exalenz Bioscience Description and Business Overview
Table 122. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 124. Exalenz Bioscience Recent Development
Table 125. GENFIT Corporation Information
Table 126. GENFIT Description and Business Overview
Table 127. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 129. GENFIT Recent Development
Table 130. Siemens Healthineers Corporation Information
Table 131. Siemens Healthineers Description and Business Overview
Table 132. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 134. Siemens Healthineers Recent Development
Table 135. ONE WAY LIVER Corporation Information
Table 136. ONE WAY LIVER Description and Business Overview
Table 137. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 139. ONE WAY LIVER Recent Development
Table 140. Prometheus Laboratories Corporation Information
Table 141. Prometheus Laboratories Description and Business Overview
Table 142. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 144. Prometheus Laboratories Recent Development
Table 145. Gilead Sciences Corporation Information
Table 146. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Gilead Sciences Description and Business Overview
Table 148. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 149. Gilead Sciences Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
Table 153. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List
Table 154. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
Table 155. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers
Table 156. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
Table 157. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Picture
Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Diagnostic Centers Examples
Figure 8. Others Examples
Figure 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers: 2016 & 2020
Figure 28. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Type (2016-2021)
Figure 30. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Application (2016-2021)
Figure 32. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 34. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 35. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 36. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 37. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 38. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 39. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 40. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 41. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 42. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 43. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
Figure 44. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 47. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 48. Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biopredictive Quest Diagnostics Exalenz Bioscience GENFIT Siemens Healthineers ONE WAY LIVER Prometheus Laboratories Gilead Sciences